South & Central America Acute Pancreatitis Market Forecast to 2030

According to the research team’ research, the South & Central America acute pancreatitis market was valued at US$ 209.04 million in 2022 and is expected to reach US$ 333.67 million by 2030, registering a CAGR of 6.0% from 2022 to 2030. Rise in pancreatic cancer cases due to acute pancreatitis, rising incidence of diabetes following acute pancreatitis, and advancements in specific acute pancreatitis treatments are among the critical factors attributed to the South & Central America acute pancreatitis market expansion.

Acute pancreatitis is an inflammatory disorder of the pancreas. The condition is associated with increased morbidity and mortality because there is no specific treatment approved to treat it, leaving supportive care as the main course of treatment. A targeted novel treatment strategy that halts disease progression and improves patient outcomes is needed to address the current disease burden of acute and severe acute pancreatitis. An article published in the National Library of Medicine in February 2023 focuses on 3 major approaches to advance acute pancreatitis treatments—the clinical identification and application of new genetic information; newly identified serum biomarkers, i.e., fatty acid ethyl esters (FAEEs); and acceleration in timing of early nutrition feedings in acute pancreatitis.

Clinical Identification and Application of New Genetic Information: When acute pancreatitis occurs at the age of 35 years or when it is relapsing or idiopathic, testing for the 6 commercially evaluable genetic causes of acute pancreatitis is recommended. This test provides valuable information regarding the diagnosis probability of genetic predisposition, cofactors that are likely to play a role in disease identification and a suitable approach to initiate treatment early in the process, without requiring repeated testing. Newly Identified Serum Biomarkers—FAEEs: During a prospective, blinded trial, researchers compared the levels of FAEE, nonesterified fatty acids, and ethanol in the blood of 175 patients hospitalized for alcoholic pancreatitis, alcohol intoxication, nonalcoholic pancreatitis, and normal controls. This test has the unique capability of demonstrating diagnostic elevations of FAEEs associated with alcohol consumption. Therefore, it can be evaluated that alcohol is the cause of alcohol-associated pancreatitis and to exclude it when there are other causes. Important Acceleration in Timing of Early Feedings in Acute Pancreatitis: The practice of beginning early feeding through the nasogastric/nasojejunal routes after the onset of acute pancreatitis has been supported by multiple randomized controlled trials and has replaced the practice of resting the gastrointestinal tract until pain subsides prior to feeding. This approach results in increased bowel motility and reduced organ failure, infection, length of stay, and mortality rates, confirming that an idle intestine leads to bacterial overgrowth, increased permeability, and bacterial translocation. Such developments in specific treatment approaches would lead to new treatment options to enhance outcomes and improve the South & Central America acute pancreatitis market in the near future.

On the contrary, side effects of pancreatitis and pancreatic cancer treatments hampers on the growth of South & Central America acute pancreatitis market.

Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held 56.3% share of South & Central America acute pancreatitis market in 2022, amassing US$ 117.64 million. It is projected to garner US$ 186.62 million by 2030 to expand at 5.9% CAGR during 2022–2030.

Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held 47.2% share of South & Central America acute pancreatitis market in 2022, amassing US$ 98.72 million. It is projected to garner US$ 162.11 million by 2030 to expand at 6.4% CAGR during 2022–2030.

Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held 74.8% share of South & Central America acute pancreatitis market in 2022, amassing US$ 156.46 million. It is projected to garner US$ 248.14 million by 2030 to expand at 5.9% CAGR during 2022–2030.

Based on country, the South & Central America acute pancreatitis market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states the Rest of South & Central America captured 38.0% share of South & Central America acute pancreatitis market in 2022. It was assessed at US$ 79.50 million in 2022 and is likely to hit US$ 123.69 million by 2030, exhibiting a CAGR of 5.7% CAGR during 2022–2030.

Key players operating in the South & Central America acute pancreatitis market are Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare, among others.

In Oct 2021, Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, introduced the V8, a new high-end ultrasound system that provides enhanced image quality, usability and convenience for all medical professionals.

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Acute Pancreatitis Market Landscape
4.1 Overview
5. South & Central America Acute Pancreatitis Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. Acute Pancreatitis Market – South & Central America Market Analysis
6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings
7.1 Overview
7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes
8.1 Overview
8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Acute Pancreatitis Market – Country Analysis
10.1 Overview
10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. South & Central America Acute Pancreatitis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boston Scientific Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Kabi AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

Table 1. South & Central America Acute Pancreatitis Market Segmentation
Table 2. South & Central America Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the South & Central America Acute Pancreatitis Market
Table 20. Recent Organic Growth Strategies in the South & Central America Acute Pancreatitis Market
Table 21. Glossary of Terms, South & Central America Acute Pancreatitis Market

Figure 1. South & Central America Acute Pancreatitis Market Segmentation, By Country
Figure 2. South & Central America Acute Pancreatitis Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 21. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the South & Central America Acute Pancreatitis Market